A new genetic test will allow rapid diagnosis and earlier treatment of a debilitating neuromuscular condition. Newcastle University scientists have identified a new gene which will allow rapid ...

The gene, GFPT1, has been identified by researchers at Newcastle University working with international colleagues, as crucial in causing a variation of Congenital Myasthenic Syndrome (CMS).